Upregulation of IL‐6 expression in human salivary gland cell line by IL‐17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF‐κB pathways
- 14 July 2018
- journal article
- research article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (9) , 847-855
Abstract
Background The human salivary gland cell line (HSG) has so far been used as in vitro models for study of the influence of cytokines and pharmacologic agents on salivary glands, as well as a model system for inflammation in Sjögren's syndrome (SS). This study aimed to determine the effect of IL‐17 on IL‐6 production and the underlying molecular mechanism regulated by the HSG cell line. Methods Immunofluorescence analyses, RT‐PCR, and Western blot were conducted to evaluate the IL‐17 receptor (IL‐17R) expression in cultured HSG cells. Real‐time PCR and ELISA were then utilized to establish the mRNA and protein levels of IL‐6 in IL‐17‐stimulated HSG cells. Western blot, flow cytometry, immunofluorescence and inhibitor analyses were conducted to elucidate the involved signaling pathways. Results The HSG cells reliably expressed the IL‐17R mRNA and its encoded surface‐bound protein. The expression of IL‐6 mRNA and protein was upregulated by stimulation of HSG cells with IL‐17; this effect was impeded by IL‐17 or IL‐17R‐neutralizing antibodies. IL‐17 stimulation ended up with the fast phosphorylation of p38 mitogen‐activated protein kinase (MAPK), extracellular signal‐regulated kinase (ERK), Akt, and translocation of nuclear factor‐kappaB (NF‐κB) in the HSG cells. p38 MAPK, Akt, and NF‐κB inhibitors significantly subdued IL‐6 generation in HSG cells stimulated by IL‐17. PD98059, an ERK inhibitor, decreased IL‐6 generation under low‐dose of IL‐17 but not with high‐dose. Conclusions The HSG cells expressed IL‐17R and reacted to IL‐17 to generate IL‐6 via the stimulation of ERK, p38 MAPK, Akt, and NF‐κB signaling pathways.Keywords
Funding Information
- National Natural Science Foundation of China (81500878, 81570995)
This publication has 26 references indexed in Scilit:
- Expression of IL-17, IL-23 and Their Receptors in Minor Salivary Glands of Patients with Primary Sjögren's SyndromeJournal of Immunology Research, 2012
- Effect of interleukin-17 on the expression of chemokines in gingival epithelial cellsEuropean Journal of Oral Sciences, 2011
- IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathwaysMolecular Immunology, 2011
- IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transferLaboratory Investigation, 2010
- New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndromeClinical and Experimental Immunology, 2010
- IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-α and IL-1βAmerican Journal of Physiology-Renal Physiology, 2010
- Cytokines in Sjögren’s syndromeOral Diseases, 2009
- Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome ImmunopathogenesisThe American Journal of Pathology, 2009
- RAGE expression and NF‐κB activation attenuated by extracellular domain of RAGE in human salivary gland cell lineJournal of Cellular Physiology, 2009
- Th17 cells in human diseaseImmunological Reviews, 2008